drugset / Trial / NCT01448031

A Healthy Female and Male Volunteers Aspirin Study

NCT01448031

Phase 1 Completed 54 enrolled AstraZeneca
RandomizedCrossoverOpen-labelDiagnostic

Summary

This is a study to compare the bioavailability of Acetyl Salicylic Acid (ASA) between Esomeprazole and Aspirin after multiple dose administration.

Timeline

Start
2011-11
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 80 mg
Subject Aspirin Small molecule 81 mg
Background Esomeprazole Small molecule 20 mg

Indications

No indication recorded.